Financial statements Bio-Ksel
Balance sheet data of BIO-KSEL
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 2 722 735,09 | 2 915 546,44 | 2 647 613,85 | 3 051 926,48 | 3 269 271,56 | 3 240 243,00 |
A. Fixed assets | 822 996,31 | 767 692,75 | 699 541,62 | 754 084,26 | 1 240 163,29 | 1 274 285,11 |
B. Current assets | 1 899 738,78 | 2 147 853,69 | 1 948 072,23 | 2 297 842,22 | 2 029 108,27 | 1 965 957,89 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 2 722 735,09 | 2 915 546,44 | 2 647 613,85 | 3 051 926,48 | 3 269 271,56 | 3 240 243,00 |
A. Equity | 897 354,25 | 994 014,57 | 881 680,63 | 1 503 292,78 | 825 713,56 | 1 550 278,27 |
B. Liabilities and provisions for liabilities | 1 825 380,84 | 1 921 531,87 | 1 765 933,22 | 1 548 633,70 | 2 443 558,00 | 1 689 964,73 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 121 790,01 |
II. Short-term liabilities | 1 825 380,84 | 1 921 531,87 | 1 765 933,22 | 1 548 633,70 | 2 282 350,51 | 1 393 901,67 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.